PBS listings to save melanoma and multiple sclerosis patients up to $128,900 a year

Australians suffering from melanoma and multiple sclerosis will soon have new treatment options, with new and amended PBS listings on the Pharmaceutical Benefits Scheme (PBS) coming into effect on 1 November.   The Morrison Government will expand the current PBS listings of Tafinlar® (dabrafenib) and Mekinist® (trametinib) to include subsidy for post-surgery treatment for patients…

Details

No room for complacency about polio

On 24 October, we mark World Polio Awareness Day, a reminder that polio is a devastating disease which could easily return if we are not vigilant.   Every Australian needs to understand how important it is to prevent a re-emergence of this debilitating disease.   Thanks to decades of diligent vaccination programs against polio, there…

Details

Launch of national women’s health survey results

The Morrison Government welcomes the launch of today’s national women’s health survey, which reflects the challenges and opportunities for the health care needs of Australian women and girls.   The fifth annual Jean Hailes National Women’s Health Survey reflects the health needs and behaviour of almost 10,000 women throughout Australia.   The survey has helped…

Details

Grant call open for research on Chronic Fatigue Syndrome

The Morrison Government is calling for proposals for $3 million in research to better understand the causes and improve diagnosis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).   Tomorrows opening of the National Health and Medical Research Council (NHMRC) competitive Targeted Call for Research (TCR) is designed to help stimulate quality collaborative research in…

Details

Life-changing medicines listings to save cystic fibrosis patients up to $250,000 a year

The Morrison Government will provide immediate access to life-changing medicines on the Pharmaceutical Benefits Scheme (PBS) to help support people with cystic fibrosis, saving them and their families up to $250,000 per year. From 1 December 2019, the life-changing cystic fibrosis medicine Symdeko® will be listed on the PBS for patients with cystic fibrosis over…

Details